|Articles|July 16, 2019

Approaches to Mitigate Blindness Associated with Neovascular Age-Related Macular Degeneration

https://www.pharmacytimes.org/on-demand/a-managed-care-review-approaches-to-mitigate-blindness-associated-with-neovascular-agerelated-macular-degeneration

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Trending on AJMC

Approaches to Mitigate Blindness Associated with Neovascular Age-Related Macular Degeneration

Related Content

Zanubrutinib Outlasting Acalabrutinib in CLL

Closing Evidence Gaps in Managed Care for Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication

What Comes After Anti-VEGF in Wet AMD: Arshad Khanani, MD

Experts Weigh Vitiligo's Cosmetic Label as Oral Therapies Near

Trending on AJMC

5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

ICER Draft Flags High Cost of New Hypertension Drug Class

GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis

Lifestyle Factors Offer Actionable Targets in MASLD Management: Zobair M. Younossi, MD